RPCEC00000117
Recruiting
Phase 4
Evaluation of molecular response to treatment with Heberprot-P in patients with diabetic foot ulcers”.
Center for Genetic Engineering and Biotechnology (CIGB).0 sites156 target enrollmentMay 20, 2011
ConditionsDiabetic foot ulcers.
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Diabetic foot ulcers.
- Sponsor
- Center for Genetic Engineering and Biotechnology (CIGB).
- Enrollment
- 156
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Have given informed consent. 2\) Patients with diabetes mellitus type 1 or 2 according to the criteria of the American Diabetes Association. 3\) Age \= 18 years. 4\) Diabetic foot ulcer deep, complicated, and no clinical signs of infection. 5\) Diabetic foot ulcer with an area \= 2 cm2\. 6\) Patients with ischemic ulcers with pressures between 0\.8 to 0\.3 index.
Exclusion Criteria
- •1\) Signs or symptoms of local infection. 2\) Complete granulating ulcer. 3\) Pretreatment with epidermal growth factor (EGF) topically or by any means in order to study injury or other injury in the 4 weeks prior to treatment with EGF. 4\) Connective tissue diseases. 5\) Decompensated or severe systemic diseases: heart disease (acute myocardial infarction in the previous three months, unstable angina or heart failure with edema), moderate or severe hepatic insufficiency, renal insufficiency with serum creatinine \> 200 umol/L. 6\) Current or history of malignancy in the past. 7\) Psychiatric or neurological diseases that prevent the patient to give consent to participate in the study. 8\) Hemoglobin \< 100 g/L. 9\) Clinical signs of malnutrition or albumin \< 30 g/L. 10\) Hypersensitivity to the product or any of its components. 11\) Pregnancy and lactation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Prospective Evaluation of the Molecular Effects of Itraconazoleas an anti-cancer agent: A Window of Opportunity Studysolid tumorsJPRN-UMIN000018388Hyogo College of Medicine20
Recruiting
Phase 2
Window trialJPRN-jRCTs051190006Tsubamoto Hiroshi200
Not yet recruiting
Phase 2
A clinical trial to study the effects photodynamic therapy in patients with gum diseases.CTRI/2024/06/068905Shweta S Patil
Recruiting
Phase 2
Study of changes in cancer tissue induced by treatment with bevacizumab in metastatic breast cancermetastatic breast cancerCancer - BreastACTRN12609000904279Georgios Kesisis40
Not yet recruiting
Phase 2
Discover the Power of Homoeopathic Calcarea Fluor 6x for Knee HealthCTRI/2024/07/071629Jawaharlal Nehru Homoeopathic Medical And Hospital